Jeremy H. Tchaicha

Jeremy H. Tchaicha is an accomplished scientific leader in the field of cancer research, currently serving as Director at Obsidian Therapeutics since November 2019, previously holding the position of Associate Director. Prior experience includes roles as Principal Scientist at Ikena Oncology, Senior Scientist at Ribon Therapeutics, and significant contributions at Infinity Pharmaceuticals, where responsibilities spanned from early discovery to IND-enabling studies. Additional experience includes postdoctoral research at Dana-Farber Cancer Institute and a Graduate Research Assistant position at The University of Texas MD Anderson Cancer Center. Jeremy H. Tchaicha holds a Ph.D. in Cancer Biology from The University of Texas Health Science Center at Houston and a B.S. in Biology from Lafayette College, showcasing a strong educational foundation that complements extensive industry experience in drug discovery and development.